Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00448942 · ClinicalTrials.gov registry record
The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections
A clinical trial, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
- Completed
- Registry status
- 5,300
- Enrollment target
NCT00448942: Completed study, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
NCT00448942 is a clinical trial that has completed, run by Hunter Holmes Mcguire Veteran Affairs Medical Center. The registered enrollment target is 5,300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00448942 has completed, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
- COMPLETED
- Registry status
- 5,300 participants
- Enrollment target
Study Summary
The purpose of this study was to determine if the use of daily chlorhexidine bathing would decrease the incidence of MRSA and VRE colonization and healthcare associated Bloodstream Infections (BSI) among Intensive Care Unit (ICU) patients.
Interventions
- BEHAVIORAL Daily bathing with Chlorhexidine based product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,300 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-01 |
What the finished NCT00448942 record still lists
NCT00448942 is an observational study that tracks outcomes without assigning an intervention. Its 5,300 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Daily bathing with Chlorhexidine based product is the first listed.
NCT00448942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00448942 about?
NCT00448942 is a clinical study titled "The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections". The purpose of this study was to determine if the use of daily chlorhexidine bathing would decrease the incidence of MRSA and VRE colonization and healthcare associated Bloodstream Infections (BSI) among Intensive Care Unit (ICU) patients.
What is the current status of trial NCT00448942?
This trial is currently completed. The enrollment target is 5,300 participants. The study started on 2004-11. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00448942?
The interventions under investigation include: Daily bathing with Chlorhexidine based product (BEHAVIORAL).
Who is sponsoring clinical trial NCT00448942?
This trial is sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
- NCT05836987 · 5,350 participants · Phase 3
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia